87 related articles for article (PubMed ID: 1686733)
1. Inhibitory effect of calcitonin on growth hormone response to growth hormone releasing hormone in acromegaly.
Sarno-Moraes CR; Czepielewski MA; Vieira JG; Chacra AR; Lengyel AM
Braz J Med Biol Res; 1991; 24(10):1003-9. PubMed ID: 1686733
[TBL] [Abstract][Full Text] [Related]
2. Calcitonin suppresses growth hormone (GH) response to growth hormone-releasing hormone (GHRH) in man.
Lengyel AM; Toledo AL; Czepielewski MA; Vieira JG; Chacra AR
J Endocrinol Invest; 1989 Jan; 12(1):25-9. PubMed ID: 2545765
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of calcitonin-induced growth hormone (GH) suppression: roles of somatostatin and GH-releasing factor.
Lengyel AM; Tannenbaum GS
Endocrinology; 1987 Apr; 120(4):1377-83. PubMed ID: 2881773
[TBL] [Abstract][Full Text] [Related]
4. Effects of intranasal calcitonin administration on pituitary GH response to hGHRH (1-29)NH2 in normal adult subjects.
Giustina A; Romanelli G; Doga M; Pizzocolo G; Giustina G
Clin Endocrinol (Oxf); 1989 Jun; 30(6):699-704. PubMed ID: 2556224
[TBL] [Abstract][Full Text] [Related]
5. Studies on the response of growth hormone (GH) secretion to GH-releasing hormone, thyrotropin-releasing hormone, gonadotropin-releasing hormone, and somatostatin in acromegaly.
Shibasaki T; Hotta M; Masuda A; Imaki T; Obara N; Hizuka N; Takano K; Wakabayashi I; Demura H; Ling N
J Clin Endocrinol Metab; 1986 Jul; 63(1):167-73. PubMed ID: 2872226
[TBL] [Abstract][Full Text] [Related]
6. Effects of theophylline infusion on the growth hormone (GH) and prolactin response to GH-releasing hormone administration in acromegaly.
Losa M; Alba-Lopez J; Schopohl J; Sobiesczcyk S; Chiodini PG; Müller OA; von Werder K
J Endocrinol Invest; 1988 Oct; 11(9):663-7. PubMed ID: 3146595
[TBL] [Abstract][Full Text] [Related]
7. Growth hormone (GH) and prolactin responses to repetitive administration of GH-releasing hormone in acromegaly.
Losa M; Schopohl J; König A; Müller OA; von Werder K
J Clin Endocrinol Metab; 1986 Aug; 63(2):475-80. PubMed ID: 3088026
[TBL] [Abstract][Full Text] [Related]
8. Effects of hypophysiotropic factors on growth hormone and prolactin secretion from somatotroph adenomas in culture.
Ishibashi M; Yamaji T
J Clin Endocrinol Metab; 1985 May; 60(5):985-93. PubMed ID: 2858494
[TBL] [Abstract][Full Text] [Related]
9. Effects of calcitonin on GH response to pyridostigmine in combination with hGHRH (1-29) NH2 in normal adult subjects.
Giustina A; Bodini C; Bossoni S; Doga M; Girelli A; Pizzocolo G; Wehrenberg WB
Clin Endocrinol (Oxf); 1990 Sep; 33(3):375-80. PubMed ID: 2147598
[TBL] [Abstract][Full Text] [Related]
10. Growth hormone-releasing hormone infusion in patients with active acromegaly.
Losa M; Chiodini PG; Liuzzi A; König A; Müller OA; Schopohl J; von Werder K
J Clin Endocrinol Metab; 1986 Jul; 63(1):88-93. PubMed ID: 3086362
[TBL] [Abstract][Full Text] [Related]
11. Characterization of growth hormone-releasing hormone receptors in pituitary adenomas from patients with acromegaly.
Ikuyama S; Natori S; Nawata H; Kato K; Ibayashi H; Kariya T; Sakai T; Rivier J; Vale W
J Clin Endocrinol Metab; 1988 Jun; 66(6):1265-71. PubMed ID: 2836473
[TBL] [Abstract][Full Text] [Related]
12. Medical management of acromegaly due to ectopic production of growth hormone-releasing hormone by a carcinoid tumor.
Melmed S; Ziel FH; Braunstein GD; Downs T; Frohman LA
J Clin Endocrinol Metab; 1988 Aug; 67(2):395-9. PubMed ID: 2899089
[TBL] [Abstract][Full Text] [Related]
13. Acromegaly due to ectopic growth hormone (GH)-releasing hormone (GHRH) production: dynamic studies of GH and ectopic GHRH secretion.
Barkan AL; Shenker Y; Grekin RJ; Vale WW; Lloyd RV; Beals TF
J Clin Endocrinol Metab; 1986 Nov; 63(5):1057-64. PubMed ID: 3093517
[TBL] [Abstract][Full Text] [Related]
14. The control on growth hormone release by free fatty acids is maintained in acromegaly.
Lanzi R; Losa M; Mignogna G; Caumo A; Pontiroli AE
J Clin Endocrinol Metab; 1999 Apr; 84(4):1234-8. PubMed ID: 10199760
[TBL] [Abstract][Full Text] [Related]
15. In obesity the somatotrope response to either growth hormone-releasing hormone or arginine is inhibited by somatostatin or pirenzepine but not by glucose.
Maccario M; Procopio M; Grottoli S; Oleandri SE; Razzore P; Camanni F; Ghigo E
J Clin Endocrinol Metab; 1995 Dec; 80(12):3774-8. PubMed ID: 8530634
[TBL] [Abstract][Full Text] [Related]
16. Regulation of pulsatile growth hormone secretion by fasting in normal subjects and patients with acromegaly.
Ho PJ; Friberg RD; Barkan AL
J Clin Endocrinol Metab; 1992 Sep; 75(3):812-9. PubMed ID: 1517371
[TBL] [Abstract][Full Text] [Related]
17. Lack of desensitization of adenomatous somatotrophs to growth-hormone releasing hormone in acromegaly.
Spada A; Elahi FR; Arosio M; Sartorio A; Guglielmino L; Vallar L; Faglia G
J Clin Endocrinol Metab; 1987 Mar; 64(3):585-91. PubMed ID: 3102543
[TBL] [Abstract][Full Text] [Related]
18. In obesity, glucose load loses its early inhibitory, but maintains its late stimulatory, effect on somatotrope secretion.
Grottoli S; Procopio M; Maccario M; Zini M; Oleandri SE; Tassone F; Valcavi R; Ghigo E
J Clin Endocrinol Metab; 1997 Jul; 82(7):2261-5. PubMed ID: 9215304
[TBL] [Abstract][Full Text] [Related]
19. Alpha 2-adrenergic agonism enhances the growth hormone (GH) response to GH-releasing hormone through an inhibition of hypothalamic somatostatin release in normal men.
Devesa J; Arce V; Lois N; Tresguerres JA; Lima L
J Clin Endocrinol Metab; 1990 Dec; 71(6):1581-8. PubMed ID: 1977761
[TBL] [Abstract][Full Text] [Related]
20. Impaired inhibitory effects of somatostatin on growth hormone (GH)-releasing hormone stimulation of GH secretion after short term infusion.
Kelijman M; Frohman LA
J Clin Endocrinol Metab; 1990 Jul; 71(1):157-63. PubMed ID: 1973420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]